FDA Reports 2 More Contaminated NECC Drugs

The FDA has reported the presence of bacteria in two additional drugs manufactured and distributed from the New England Compounding Center in Framingham, Mass., according to an AHA News Now report.

Advertisement

 

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

Contamination was found in three lots of injectable betamethasone and one lot of cardioplegia solution. So far, the federal government has not reported any infections linked to these lots and is not changing its recommendations for diagnosing and treating patients who have received NECC products.

Over the course of the last several months, federal agencies have confirmed contaminated epidural steroid injections manufactured at NECC are linked to a meningitis outbreak that has injected hundreds of patients and killed 29.

More Articles on Patient Safety:

NQF Endorses Neurology, Behavioral Health Measures

5 Ways to Improve Outcomes for Neurosurgery Patients

Patient Safety Tool: Sample Fire Safety Plan

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

  • A Pleasant View, Utah-based physician has been indicted on charges of obtaining unapproved drugs from China and selling them to…

  • From payer obstacles to operational pressures, five ASC leaders discuss the biggest frictions they’re facing. Note: Responses were lightly edited.…

Advertisement

Comments are closed.